393 related articles for article (PubMed ID: 33364198)
21. CEREBRAL ORGANOIDS AS A MODEL FOR GLIOBLASTOMA MULTIFORME.
Silvia N; Dai G
Curr Opin Biomed Eng; 2020 Mar; 13():152-159. PubMed ID: 32355905
[TBL] [Abstract][Full Text] [Related]
22. Modeling Tumor Immunology and Immunotherapy in Mice.
Buqué A; Galluzzi L
Trends Cancer; 2018 Sep; 4(9):599-601. PubMed ID: 30149876
[TBL] [Abstract][Full Text] [Related]
23. Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies.
Magré L; Verstegen MMA; Buschow S; van der Laan LJW; Peppelenbosch M; Desai J
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37220953
[TBL] [Abstract][Full Text] [Related]
24. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
25. Development of a human glioblastoma model using humanized DRAG mice for immunotherapy.
Srivastava R; Labani-Motlagh A; Chen A; Yang F; Ansari D; Patel S; Ji H; Trasti S; Dodda M; Patel Y; Zou H; Hu B; Yi G
bioRxiv; 2023 Feb; ():. PubMed ID: 36824969
[TBL] [Abstract][Full Text] [Related]
26. Neoantigen discovery and applications in glioblastoma: An immunotherapy perspective.
Wang C; Yu M; Zhang W
Cancer Lett; 2022 Dec; 550():215945. PubMed ID: 36216148
[TBL] [Abstract][Full Text] [Related]
27. The Organoid Era Permits the Development of New Applications to Study Glioblastoma.
Andreatta F; Beccaceci G; Fortuna N; Celotti M; De Felice D; Lorenzoni M; Foletto V; Genovesi S; Rubert J; Alaimo A
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182346
[TBL] [Abstract][Full Text] [Related]
28. Advances in Nanotechnology-Based Immunotherapy for Glioblastoma.
Tang L; Zhang M; Liu C
Front Immunol; 2022; 13():882257. PubMed ID: 35651605
[TBL] [Abstract][Full Text] [Related]
29. Patient-Derived Organoids for Precision Cancer Immunotherapy.
Grönholm M; Feodoroff M; Antignani G; Martins B; Hamdan F; Cerullo V
Cancer Res; 2021 Jun; 81(12):3149-3155. PubMed ID: 33687948
[TBL] [Abstract][Full Text] [Related]
30. Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion.
Darrigues E; Zhao EH; De Loose A; Lee MP; Borrelli MJ; Eoff RL; Galileo DS; Penthala NR; Crooks PA; Rodriguez A
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639060
[TBL] [Abstract][Full Text] [Related]
31. Spontaneous Glioblastoma Spheroid Infiltration of Early-Stage Cerebral Organoids Models Brain Tumor Invasion.
da Silva B; Mathew RK; Polson ES; Williams J; Wurdak H
SLAS Discov; 2018 Sep; 23(8):862-868. PubMed ID: 29543559
[TBL] [Abstract][Full Text] [Related]
32. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
[TBL] [Abstract][Full Text] [Related]
33. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
[TBL] [Abstract][Full Text] [Related]
34. A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma.
Reed MR; Lyle AG; De Loose A; Maddukuri L; Learned K; Beale HC; Kephart ET; Cheney A; van den Bout A; Lee MP; Hundley KN; Smith AM; DesRochers TM; Vibat CRT; Gokden M; Salama S; Wardell CP; Eoff RL; Vaske OM; Rodriguez A
Cells; 2021 Dec; 10(12):. PubMed ID: 34943910
[TBL] [Abstract][Full Text] [Related]
35. Advances in immunotherapy for the treatment of glioblastoma.
Tivnan A; Heilinger T; Lavelle EC; Prehn JH
J Neurooncol; 2017 Jan; 131(1):1-9. PubMed ID: 27743144
[TBL] [Abstract][Full Text] [Related]
36. Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples.
Choi SI; Jeon AR; Kim MK; Lee YS; Im JE; Koh JW; Han SS; Kong SY; Yoon KA; Koh YH; Lee JH; Lee WJ; Park SJ; Hong EK; Woo SM; Kim YH
Front Oncol; 2019; 9():875. PubMed ID: 31572675
[TBL] [Abstract][Full Text] [Related]
37. Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma.
Nickl V; Eck J; Goedert N; Hübner J; Nerreter T; Hagemann C; Ernestus RI; Schulz T; Nickl RC; Keßler AF; Löhr M; Rosenwald A; Breun M; Monoranu CM
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345035
[TBL] [Abstract][Full Text] [Related]
38. Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments.
Gómez-Oliva R; Domínguez-García S; Carrascal L; Abalos-Martínez J; Pardillo-Díaz R; Verástegui C; Castro C; Nunez-Abades P; Geribaldi-Doldán N
Front Oncol; 2020; 10():614295. PubMed ID: 33585240
[TBL] [Abstract][Full Text] [Related]
39. Exploring Tumor-Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients.
Jeong SR; Kang M
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834057
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic strategies of recurrent glioblastoma and its molecular pathways 'Lock up the beast'.
El-Khayat SM; Arafat WO
Ecancermedicalscience; 2021; 15():1176. PubMed ID: 33680090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
